|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation expense | |||||
| Non-cash operating lease expense | |||||
| Net amortization of premium or discount on investments | |||||
| Losses (gains) on foreign exchange | |||||
| Changes in operating assets and liabilities, net of effects of business combinations: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Deferred contract acquisition costs | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of short-term investments | |||||
| Maturities and sales of short-term investments | |||||
| Maturities of short-term investments | |||||
| Sales of short-term investments | |||||
| Total maturities and sales of short-term investments | |||||
| Purchases of property and equipment | |||||
| Payments for business combinations, net of cash acquired | |||||
| Purchases of intangible asset | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from exercise of share options | |||||
| Proceeds from employee share purchase plan | |||||
| Proceeds from employee equity transactions, net of payments to tax authorities and employees | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash—beginning of period | |||||
| Cash, cash equivalents, and restricted cash—end of period | |||||
| Income tax payments (refunds) | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Purchase of property and equipment during the period included in accounts payable | |||||
| Fair value of ordinary shares issued as consideration for business combination | |||||
| Fair value of replacement awards in business combination | |||||
Loading...